Hemolysin, specifically, plays a crucial role by disrupting the cancer cell membrane, leading to mitochondrial dysfunction and the activation of apoptotic pathways, including caspase-3 and caspase-4, which are more sensitively triggered in cancer cells than in normal cells. This evidence concerns the gene CASP4 and cancer.